Amerikanische Gesellschaft für Hirudotherapie

Transcripts involved in hemostasis: exploring salivary complexes from Haementeria vizottoi leeches through transcriptomics

Transcriptomics study published in Toxicon (2015)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Genomik & ProteomikSpeichel-PharmakologieAmorim AM et al. · Toxicon, 2015

Abstract

Throughout evolution, parasites have adapted in order to successfully intervene in the host defense, producing specific peptides and proteins. Interestingly, these peptides and proteins have been exploited as potential drug candidates against several diseases. Furthermore, biotechnology studies and cDNA libraries have remarkably contributed to identify potentially bioactive molecules. In this regard, herein, a cDNA library of salivary complexes from Haementeria vizottoi leeches was constructed, the transcriptome was characterized and a phylogenetic analysis was performed considering antistasin-like and antiplatelet-like proteins. Hundred twenty three transcripts were identified coding for putative proteins involved in animal feeding (representing about 10% of the expression level). These sequences showed similarities with myohemerythrins, carbonic anhydrases, anticoagulants, antimicrobials, proteases and protease inhibitors. The phylogenetic analysis, regarding antistasin-like and antiplatetlet-like proteins, revealed two main clades in the Rhynchobdellida leeches. As expected, the sequences from H. vizottoi have presented high similarities with those types of proteins. Thus, our findings could be helpful not only to identify new coagulation inhibitors, but also to better understand the biological composition of the salivary complexes.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, Non-U.S. Gov't
Indexed MeSH termsAnimalsAnticoagulantsComputational BiologyFeeding BehaviorGene Expression ProfilingGene LibraryHemostasisLeechesModels, MolecularPhylogenyPlatelet Aggregation InhibitorsRNA, Messenger

Zusammenfassung

Salivary transcriptome of Haementeria vizottoi (Brazilian leech) identifying novel hementins, hementerins, saratin-like and Kazal-type inhibitor families.

Warum dies für die Hirudotherapie relevant ist

This study constructed a cDNA library from the salivary complexes of the leech Haementeria vizottoi and characterized its transcriptome, identifying 123 transcripts coding for putative proteins involved in animal feeding, representing about 10% of the expression level. The identified sequences showed similarities to anticoagulants, antimicrobials, proteases, protease inhibitors, myohemerythrins, and carbonic anhydrases. The abstract states that these findings could be helpful to identify new coagulation inhibitors and to better understand the biological composition of the salivary complexes. The relevance to the leech secretome is the characterization of salivary transcript diversity in this species. The limitation is that the findings are descriptive, based on sequence homology and phylogenetic analysis, with no functional validation of the identified transcripts presented in the abstract.

Zitation

Transcripts involved in hemostasis: exploring salivary complexes from Haementeria vizottoi leeches through transcriptomics.

Amorim AM et al. · Toxicon, 2015

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.